sunstone.eu

Sunstone Life Science Ventures - European venture capital investment f...

Go to sunstone.eu

Sunstone. Sunstone Life Science Ventures is an independent European venture capital investment firm. We enable and empower life science...

Read Sunstone.eu news digest here: view the latest Sunstone articles and content updates right away or get to their most visited pages. Sunstone.eu is not yet rated by Alexa. It seems that Sunstone content is notably popular in Germany, as 43% of all users (2.1K visits per month) come from this country. We haven’t detected security issues or inappropriate content on Sunstone.eu and thus you can safely use it. Sunstone.eu is hosted with Hosting space (Denmark) and its basic language is English.

  • Content verdict: Safe
  • Website availability: Live
  • English language flagLanguage: English
  • Last check:

  • 163

    Visitors daily

  • 489

    Pageviews daily

  • 5

    Google PR

  • N/A

    Alexa rank

Sunstone.eu news digest

  • 6 months

    Are Series A radically growing?

    If you are in the biotech venture capital business, it’s been difficult to avoid conversations about the increasing sizes of Series A financing rounds. We’ve been hearing and reading about a revival of biotech financing, including “Biotech Financing...

  • 7 months

    Hans T. Scambye joins Sunstone as Venture Partner

    Hans T. Scambye joins Sunstone as Venture Partner
    Sunstone is delighted to announce that experienced biotech executive and CEO of Galecto Hans T. Schambye will be joining our team as new Venture Partner as of 1st February 2025.
    With a background as an MD and PhD Hans brings to Sunstone over 25 years of experience within corporate strategy, drug discovery and development and financing of biotech companies....

  • 8 months

    Neumirna Therapeutics secures euro 20M in Series A financing

    Neumirna Therapeutics secures euro 20M in Series A financing
    Neumirna Therapeutics (‘Neumirna’), an RNA-focused biotech company developing next-generation therapeutics for neurological disorders, is pleased to announce the first closing of its Series A funding round at €20M. The investment was co-led by new investors...

  • 1 year

    Saving Lives with Venture Capital

    In 2023 we posted our thoughts on how to calculate the potential lifesaving impact of biotech venture capital (https://bit.ly/3z4mL0o) – and we promised to expand on the topic. Unfortunately, or rather fortunately, we got busy making investments in DioGenX...

Domain history

Web host: Hosting space
Registrar: EURID
Registrant:
Updated: January 01, 1970
Expires: January 01, 1970
Created: January 01, 1970

Whois record

Safety scores

Trustworthiness

N/A

Child safety

N/A

Newly added profiles

More projects to check

Sites on this web host